Total Payments
$3,921
2024 Payments
$1,495
Companies
34
Transactions
166
Medicare Patients
1,087
Medicare Billing
$239,430
Payment Breakdown by Category
Food & Beverage$3,921 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,921 | 166 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $993.11 | 21 | $0 (2024) |
| PFIZER INC. | $445.16 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $280.81 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $202.61 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $187.66 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $183.23 | 4 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $165.55 | 8 | $0 (2024) |
| Incyte Corporation | $154.57 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $150.65 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $126.70 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,495 | 70 | GlaxoSmithKline, LLC. ($187.66) |
| 2023 | $960.41 | 51 | PFIZER INC. ($192.66) |
| 2022 | $759.96 | 33 | Janssen Biotech, Inc. ($405.31) |
| 2021 | $601.04 | 10 | Janssen Biotech, Inc. ($423.02) |
| 2020 | $91.90 | 1 | Seagen Inc. ($91.90) |
| 2017 | $13.23 | 1 | PFIZER INC. ($13.23) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.22 | General |
| 11/21/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: DESMOID TUMORS | ||||||
| 11/11/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 11/07/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Oncology | ||||||
| 11/07/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.75 | General |
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.22 | General |
| 10/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 315 | 1,361 | $742,715 | $74,830 |
| 2022 | 18 | 445 | 25,517 | $866,212 | $94,893 |
| 2021 | 14 | 314 | 17,879 | $349,392 | $67,438 |
| 2020 | 1 | 13 | 13 | $6,578 | $2,269 |
Total Patients
1,087
Total Services
44,770
Medicare Billing
$239,430
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 219 | $66,702 | $22,841 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 120 | $48,480 | $17,268 | 35.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 73 | $487,267 | $10,311 | 2.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $32,088 | $10,162 | 31.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 19 | 92 | $68,356 | $9,544 | 14.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 33 | 35 | $13,720 | $1,790 | 13.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 17 | 129 | $17,286 | $1,637 | 9.5% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 14 | 38 | $4,902 | $636.58 | 13.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 21 | $3,549 | $584.01 | 16.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 578 | $364.25 | $56.85 | 15.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 132 | $48,432 | $19,938 | 41.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 41 | 156 | $105,300 | $17,745 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 156 | $43,164 | $15,887 | 36.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 12 | 65 | $432,000 | $8,878 | 2.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 47 | 47 | $24,487 | $8,514 | 34.8% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2022 | 17 | 57 | $41,553 | $8,100 | 19.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 35 | 277 | $33,794 | $3,670 | 10.9% |
| J0640 | Injection, leucovorin calcium, per 50 mg | Office | 2022 | 18 | 1,007 | $23,549 | $3,206 | 13.6% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 15 | 46 | $14,168 | $2,564 | 18.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 20 | 83 | $12,782 | $2,031 | 15.9% |
| J9263 | Injection, oxaliplatin, 0.5 mg | Office | 2022 | 16 | 20,521 | $47,256 | $981.61 | 2.1% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2022 | 18 | 564 | $11,428 | $915.29 | 8.0% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 20 | 860 | $17,557 | $721.77 | 4.1% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2022 | 13 | 36 | $3,204 | $610.49 | 19.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 12 | 19 | $2,926 | $527.01 | 18.0% |
About Dr. Tiffany George, MD
Dr. Tiffany George, MD is a Hematology & Oncology healthcare provider based in Weston, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1780004283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tiffany George, MD has received a total of $3,921 in payments from pharmaceutical and medical device companies, with $1,495 received in 2024. These payments were reported across 166 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,921).
As a Medicare-enrolled provider, George has provided services to 1,087 Medicare beneficiaries, totaling 44,770 services with total Medicare billing of $239,430. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Weston, FL
- Active Since 04/23/2014
- Last Updated 07/10/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780004283
Products in Payments
- ERLEADA (Drug) $798.72
- KEYTRUDA (Biological) $280.81
- DARZALEX (Biological) $194.39
- OPDIVO (Biological) $183.23
- LONSURF (Drug) $165.55
- Enhertu (Drug) $126.70
- XGEVA (Biological) $125.00
- OJJAARA (Drug) $114.30
- JAKAFI (Drug) $108.94
- BOSULIF (Drug) $102.53
- XTANDI (Drug) $102.16
- TUKYSA (Drug) $91.90
- XALKORI (Drug) $78.29
- JEMPERLI (Biological) $73.36
- INLYTA (Drug) $72.12
- KISQALI (Drug) $68.66
- ICLUSIG (Drug) $62.83
- Lenvima (Drug) $52.95
- Fabhalta (Drug) $49.14
- VERZENIO (Drug) $48.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Weston
Dr. Chakra Chaulagain, Md, MD
Hematology & Oncology — Payments: $172,661
Hematology & Oncology $172,661
Adedayo Onitilo, Md, MD
Hematology & Oncology — Payments: $120,319
Hematology & Oncology $120,319
Chieh-Lin Fu, M.d, M.D
Hematology & Oncology — Payments: $16,690
Hematology & Oncology $16,690
Evan Alley, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $10,998
Hematology & Oncology $10,998
Dr. Arun Nagarajan, Md, MD
Hematology & Oncology — Payments: $5,171
Hematology & Oncology $5,171
Dr. Diana Saravia, M.d, M.D
Hematology & Oncology — Payments: $3,022
Hematology & Oncology $3,022